Cellromax Science Co (471820.KQ) Stock Price

Cellromax Science Co Price

CLOSED
4,080.00
​
Market closed

Over the last 3 years Cellromax Science Co grew revenue by 1.6% annually, reaching 22.13 B KRW. Earnings per share have declined at 13.5% per year over the last 3 years. For Cellromax Science Co, the net margin of 13.4% is down versus 22.4% a few years ago. At today's price the dividend yield works out to roughly 2.08%. The payout ratio is around 32% of earnings.

Cellromax Science Co stock price

Access this data via the Eulerpool API

Cellromax Science Co business model & stock analysis

Cellromax Science Co Ltd is a KR-based company operating in industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2024-12-13. Cellromax Science Co Ltd is a Korea-based company primarily engaged in the development and distribution of health food products. The firm primarily engages in the development and distribution of health functional foods, functional cosmetics, and general medicines. In addition, the Company’s brands include ‘Cellromax’ and so on.

Frequently asked questions about Cellromax Science Co

Converted at the current exchange rate, the Cellromax Science Co share trades at 2.71 EUR (4,080.00 KRW).

The revenue cannot currently be calculated for Cellromax Science Co.

The profit cannot currently be calculated for Cellromax Science Co.

The P/E ratio cannot be calculated for Cellromax Science Co at the moment.

The P/S cannot be calculated for Cellromax Science Co currently.

The Eulerpool Quality Score for Cellromax Science Co is 1/10.

The ISIN of Cellromax Science Co is KR7471820001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cellromax Science Co is 471820.KQ. The ticker symbol is used to trade Cellromax Science Co shares on the stock exchange.

Fair ValueTerminal
4,202.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website cellromax.kr
Country
South Korea
Currency
KRW
Initial public offering
Dec 13, 2024
ISIN
KR7471820001
Cusip
Y1R461105
Market capitalization
47.51 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
16.76
P/B Ratio
1.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.32 %
Dividend
Dividend yield
2.08 %
Payout Ratio
31.99 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 10, 2026, 3:42 PM

Cellromax Science Co Peer Group